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ypoxemia after total cavopulmonary connection is a pre-
dictable outcome in children with pulmonary arteriove-
nous fistulas (PAVF). Fontan completion is often
performed earlier than routine in these children with
a view to recruiting hepatic venous blood, which contains hepatic
factor. This has an antiangiogenic effect and is associated with re-
gression of PAVF in the medium term. Before this occurs, hypox-
emia may develop, and the purpose of this report is to highlight
the time frame over which hypoxemia may develop and the utility
of inhaled nitric oxide and orally administered pulmonary vasodila-
tors. We present the case histories of 2 children with PAVF who
underwent total cavopulmonary connection. Both patients had sig-
nificant postoperative hypoxemia associated with the presence of
PAVF. Pulmonary vasodilatation occurring as a result of anesthetic
agents and vasodilating infusions in the immediate postoperative
period may delay the onset of hypoxemia, which may respond dra-
matically to inhaled nitric oxide. Sildenafil was used in both patients
with normalization of systemic oxygen saturations over the short
term and therapy was later ceased. Although not proven by the cases
presented, we suggest that the benefit derived from sildenafil relates
to vasodilatation of resistance vessels within the pulmonary paren-
chyma, which diminishes flow through PAVF, increasing systemic
oxygenation until regression of PAVF, induced by hepatic factor,
can take place.
Clinical Summaries
PATIENT 1. This child was born at 33 weeks with mitral atresia,
ventricular septal defect, hypoplastic left ventricle, and aortic coarc-
tation. Her condition was stabilized on a prostaglandin infusion and
initial palliation included pulmonary artery banding with coarctation
repair through a left thoracotomy. Atrial septectomy was performed
at 2 months of age, and a bidirectional superior cavopulmonary con-
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months of age.
At 41months of age, the patient was clinically cyanosed. Cardiac
catheterization demonstrated PAVF with right and left pulmonary
venous saturations of 82% and 89% and low pulmonary vascular re-
sistance. An 18-mm nonfenestrated extracardiac conduit was placed
with the use of cardiopulmonary bypass, and oxygen saturation at
the end of the procedure was 98% (Figure 1). During the immediate
postoperative period, the patient remained well oxygenated and in
hemodynamically stable condition. She was extubated on the first
and discharged from intensive care on the third postoperative day.
Between postoperative days 4 and 5, the patient had several transient
periods of desaturation with readings between 36% and 69% despite
supplemental oxygen. This was attributed to the presence of PAVF
that had been identified preoperatively. Sildenafil was commenced
on day 7, at 2 mg every 6 hours, and increased to 7 mg every 6 hours
on day 9 owing to further episodes of desaturation. The patient’s ox-
ygen saturation gradually rose over several days, and she was dis-
charged on day 11, receiving 10 mg sildenafil 3 times daily. Eight
months after the procedure, the patient is well with arterial oxygen
saturations of 97%. Sildenafil has been ceased although the patient
continues to receive diuretics and angiotensin-converting enzyme
inhibitors.
PATIENT 2. The second patient was born at term with double-in-
let left ventricle, L- transposition of the great arteries, and aortic co-
arctation with a hypoplastic transverse arch. A modified Norwood
procedure with a right ventricle–pulmonary artery conduit was
performed with creation of a superior cavopulmonary connection
at 4 months.
At cardiac catheterization before Fontan completion, systemic
saturations were 65% and moderate PAVF were evident on pulmo-
nary arterial injection. Pulmonary venous saturations were 92% and
pulmonary vascular resistance was low. A 16-mm extracardiac non-
fenestrated Fontan procedure was performed with cardiopulmonary
bypass. Initial oxygen saturations of 70% improved to 87% with
high-flow oxygen (Figure 1).
On return to the intensive care unit, inhaled nitric oxide was
briefly trialed in an attempt to elevate oxygen saturations, which
were then 80% to 85%, without significant benefit and was ceased.
There was a period of hypotension and junctional rhythm necessitat-
ing a low-dose epinephrine infusion and pacing; however, satura-
tions remained stable and the child was extubated with saturations
of around 80%. Significant desaturation occurred on postoperative
day 5, necessitating reintubation, and nitric oxide was again trialed
with significant benefit to oxygenation. This improvement could not
be explained only by improved ventilation/perfusion matching. The
diagnosis of PAVF was confirmed on cardiac catheterization on day
5 (representative image, Figure 2). Sildenafil was commenced on
day 7 at a dose of 5 mg every 6 hours. This dose was increased toruary 2008
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Figure 1. Oxygen saturations in patients 1 (A) and 2 (B). ICU, Intensive care unit; CPB, cardiopulmonary bypass; iNO,
inhaled nitric oxide.7.5 mg every 6 hours, and the patient was successfully weaned from
inhaled nitric oxide and extubated on day 11. The patient was dis-
charged receiving 6.5 mg of sildenafil 3 times daily, which was
ceased 11 months after the operation. At 14 months the patient is
well, arterial oxygen saturation is 95% on room air, and the child
takes only aspirin.The Journal of ThoDiscussion
This report establishes the utility of sildenafil, an orally administered
agent that reduces pulmonary vascular resistance, in treatment of
children with hypoxemia owing to PAVF after completion of
cavopulmonary connection. Sildenafil may facilitate weaning from
ventilation with acceptable oxygenation. Increasing pulmonaryracic and Cardiovascular Surgery c Volume 135, Number 2 447
Brief CommunicationsFigure 2. A, Preoperative angiogram in
patient 1, with injection into the right in-
ternal jugular vein through the superior
cavopulmonary anastomosis, with con-
trast in both pulmonary arteries. Note
early return of contrast through arterio-
venous fistulae into pulmonary veins,
filling the common atrium from the right
side (outlined). B, Postoperative angio-
gram in patient 2, with injection into
the left pulmonary artery. Note early re-
turn of contrast via arteriovenous fistu-
las, into the pulmonary veins, outlining
the common atrium (outlined).vascular resistance in the days after operation may be associated
with worsening of hypoxemia. In our experience, sildenafil is of
use during this later period, even if use of inhaled nitric oxide in
the early postoperative period is not associated with benefit.
PAVF are a considerable cause of morbidity in the cohort of chil-
dren undergoing staged palliation before definitive total cavopulmo-
nary connection. They occur in up to 25% of patients undergoing
these procedures. Their development may be related to the absence
of ‘‘hepatic factor’’ in the hepatic venous effluent in the pulmonary
circulation that occurs after isolation of the lungs after superior cav-
opulmonary connection.1
Two earlier reports have described the use of inhaled nitric oxide
to correct critical hypoxemia owing to PAVF after staged cavopul-
monary connection.2,3 Nitric oxide lowers resistance in vascular
beds associated with well-ventilated parts of the lung, the effect of
which is more pronounced after cardiopulmonary bypass.4 This
may increase flow through physiologic right-to-left pathways, di-
verting flow away from abnormal PAVF pathways. Nitric oxide
causes smooth muscle relaxation by increasing cyclic guanosine
monophosphate levels through the actions of guanylate cyclase.
Systemic vasodilators including angiotensin-converting enzyme in-
hibitors and systemic vasodilators do not provide significant pulmo-
nary vasodilatation and in some cases may worsen intrapulmonary
shunting. Neither was used during the acute phases of the cases
described.
Sildenafil may provide both an alternative and complementary
therapy in this setting. Sildenafil prevents the breakdown of cyclic
guanosine monophosphate by inhibiting phosphodiesterase.5
Hence, it can produce pulmonary vasodilatation independent of448 The Journal of Thoracic and Cardiovascular Surgery c Febnitric oxide and may potentiate the effects of inhaled nitric oxide
on the pulmonary vasculature.
In children known to have PAVF, the development of hypox-
emia may be effectively treated with sildenafil. In those with large
PAVF, treatment may be indicated before the onset of severe hypox-
emia, which may manifest as pulmonary vascular resistance rises in
the days after cardiopulmonary bypass. We suggest that the benefit
derived from sildenafil relates to vasodilatation of the native pulmo-
nary bed, providing a lower resistance pathway than that offered by
the PAVF. Over the weeks to months after completion of the Fontan
circulation, PAVF are likely to regress as a result of hepatic factor
now reaching the pulmonary circulation, and sildenafil is no longer
required.
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